Could early ibrutinib stop CLL before it starts?
NCT ID NCT03207555
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tested whether giving the drug ibrutinib early to people with chronic lymphocytic leukemia (CLL) who have no symptoms but are at high risk for progression could be more effective than waiting. Twenty-three participants took ibrutinib daily for up to 24 months. The goal was to see how many achieved complete or partial remission, and how long they lived without the disease getting worse.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Ibrutinib (Imbruvica)
- What this could lead to
- If successful, this could show that starting ibrutinib early in high-risk CLL patients without symptoms delays disease progression and improves outcomes.
- What could go wrong
- This is a small Phase 2 trial with only 23 participants, so results may not apply to all patients. Ibrutinib has side effects like bleeding, infection, and heart issues.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC LYMPHOCYTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Low-Dose antifungal shield vulnerable patients from deadly fungal infections?
- Can a gentler chemo prep make stem cell transplants safer for blood cancer patients?
- Can a Three-Drug combo outsmart High-Risk CLL?
- Can a gentler dose of zanubrutinib keep CLL at bay in the very elderly?
- Can a Two-Drug combo wipe out hidden leukemia cells?
- Can a Chemo-Free pill combo outsmart leukemia at first diagnosis?